Hemab Therapeutics Holdings (COAG) PT Raised to $47 at Jefferies

July 13, 2026 8:51 AM

Jefferies analyst Maury Raycroft raised the price target on Hemab Therapeutics Holdings (NASDAQ: COAG) to $47.00 (from $39.00) while maintaining a Buy rating.

No results found